Assets 更改
AbbVie USD 136.22B 854M 2023-09
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Aurora Cannabis CAD 926.32M 97.51M 2023-03
Bausch Health Companies USD 27.06B 1.56B 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Canopy Growth CAD 1.67B 522.31M 2023-09
Catalent USD 9.99B 35M 2023-12
Corcept Therapeutics USD 621.52M 27.49M 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
J&J USD 166.06B 25.62B 2023-09
Merck USD 106.73B 2.26B 2023-09
Pacira USD 1.57B 39.92M 2023-12
Perrigo USD 10.76B 206.4M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Phibro Animal Health USD 964.52M 6.87M 2023-09
Prestige Brands USD 3.34B 6.88M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Supernus Pharmaceuticals USD 1.28B 7.49M 2023-12
Takeda JPY 14.87T 79.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Zoetis USD 14.29B 180M 2023-12



Glaxosmithkline 资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.